We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$72.6M
2
RNAM
Avidity Biosciences
RNAM
+$33.7M
3
CUTR
Cutera, Inc.
CUTR
+$31.5M
4
ACET icon
Adicet Bio
ACET
+$13M
5
RBAC
RedBall Acquisition Corp.
RBAC
+$12.4M

Top Sells

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$26.8M
2
PMVP icon
PMV Pharmaceuticals
PMVP
+$26.3M
3
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$16.9M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
GBTG icon
American Express Global Business Travel
GBTG
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
726
PUT
Sarepta Therapeutics
SRPT
$1.81B
– –
-12,000
Closed -$170K
STE icon
727
Steris
STE
$23.3B
– –
-1,927
Closed -$466K
SYM icon
728
Symbotic
SYM
$5.21B
– –
-131,991
Closed -$1.31M
T icon
729
AT&T
T
$165B
– –
-80,972
Closed -$1.45M
T icon
730
PUT
AT&T
T
$165B
– –
-224,550
Closed -$46K
TCOM icon
731
CALL
Trip.com Group
TCOM
$29.7B
– –
-100,000
Closed -$10K
TCOM icon
732
Trip.com Group
TCOM
$29.7B
– –
-55,619
Closed -$1.29M
TCOM icon
733
PUT
Trip.com Group
TCOM
$29.7B
– –
-105,500
Closed -$229K
TERN
734
DELISTED
Terns Pharmaceuticals
TERN
– –
-85,000
Closed -$252K
TGNA
735
CALL
DELISTED
TEGNA Inc
TGNA
– –
-421,000
Closed -$42K
UPS icon
736
CALL
United Parcel Service
UPS
$89.1B
– –
-5,000
Closed -$18K
UPS icon
737
United Parcel Service
UPS
$89.1B
– –
-1,335
Closed -$286K
UPS icon
738
PUT
United Parcel Service
UPS
$89.1B
– –
-5,000
Closed -$52K
VRM icon
739
Vroom Inc
VRM
$51.2M
– –
-576
Closed -$123K
VRM icon
740
PUT
Vroom Inc
VRM
$51.2M
– –
-1,081
Closed -$54K
VRTX icon
741
CALL
Vertex Pharmaceuticals
VRTX
$133B
– –
-15,500
Closed -$804K
VRTX icon
742
PUT
Vertex Pharmaceuticals
VRTX
$133B
– –
-15,000
Closed -$10K
WAT icon
743
Waters Corp
WAT
$40.4B
– –
-940
Closed -$292K
WBD icon
744
PUT
Warner Bros
WBD
$67.4B
– –
-222,200
Closed -$2.44M
WST icon
745
West Pharmaceutical
WST
$24.8B
– –
-1,186
Closed -$487K
XBI icon
746
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-29,900
Closed -$8K
XBI icon
747
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-50,000
Closed -$78K
XLF icon
748
State Street Financial Select Sector SPDR ETF
XLF
$59B
– –
-3,440
Closed -$132K
XLF icon
749
PUT
State Street Financial Select Sector SPDR ETF
XLF
$59B
– –
-55,000
Closed -$44K
ZBH icon
750
Zimmer Biomet
ZBH
$18.7B
– –
-3,727
Closed -$477K
28 29
30
31 32

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.